All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
JANUX THERAPEUTICS, INC. Last Reported: 4/30/2024 Stock Symbol: JANX

Business Address

10955 VISTA SORRENTO PARKWAY
SUITE 200
SAN DIEGO , CA US 92130

Mailing Address

10955 VISTA SORRENTO PARKWAY
SUITE 200
SAN DIEGO , CA US 92130
Phone Number: (858) 751-4493 / State Incorporated: DE / Fiscal Year End 12 /31

Balance Sheet

Date 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 6/30/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 2/28/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019
Cash and Cash Equivalents $212,803,000.00 $19,205,000.00 $17,152,000.00 $33,703,000.00 $30,355,000.00 $51,426,000.00 $64,752,000.00 $58,403,000.00 $35,582,000.00 $39,389,000.00 $251,625,000.00 -- -- $7,813,000.00 -- -- -- --
Accounts Receivable Net Current $500,000.00 -- -- -- $750,000.00 -- $500,000.00 -- -- -- $400,000.00 -- -- $8,000,000.00 -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets $6,384,000.00 $5,213,000.00 $5,483,000.00 $6,013,000.00 $3,774,000.00 $5,423,000.00 $5,070,000.00 $3,769,000.00 $2,054,000.00 $2,081,000.00 $2,038,000.00 -- -- $249,000.00 -- -- -- --
Total Current Assets $658,666,000.00 $349,241,000.00 $355,195,000.00 $309,302,000.00 $321,399,000.00 $332,439,000.00 $344,330,000.00 $358,065,000.00 $377,019,000.00 $389,588,000.00 $396,608,000.00 -- -- $16,062,000.00 -- -- -- --
Property Plant and Equipement $6,517,000.00 $7,003,000.00 $7,317,000.00 $7,378,000.00 $7,203,000.00 $7,086,000.00 $6,514,000.00 $3,517,000.00 $1,412,000.00 $1,118,000.00 $215,000.00 -- -- $155,000.00 -- -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Other Assets $2,524,000.00 $2,509,000.00 $2,314,000.00 $2,433,000.00 $1,611,000.00 $1,390,000.00 $1,433,000.00 $207,000.00 $392,000.00 $140,000.00 -- -- -- -- -- -- -- --
Total Assets $688,984,000.00 $380,407,000.00 $386,850,000.00 $341,500,000.00 $352,956,000.00 $364,010,000.00 $375,756,000.00 $385,365,000.00 $379,824,000.00 $391,084,000.00 $396,823,000.00 -- -- $16,217,000.00 -- -- -- --
Accounts Payable $2,254,000.00 $2,424,000.00 $2,505,000.00 $1,910,000.00 $2,051,000.00 $2,159,000.00 $2,866,000.00 $3,000,000.00 $2,458,000.00 $3,613,000.00 $354,000.00 -- -- $428,000.00 -- -- -- --
Accrued Liabilities $5,810,000.00 $7,387,000.00 $6,831,000.00 $9,216,000.00 $7,737,000.00 $8,010,000.00 $7,240,000.00 $4,043,000.00 $3,779,000.00 $2,030,000.00 $2,286,000.00 -- -- $751,000.00 -- -- -- --
Total Current Liabilities $33,221,000.00 $36,058,000.00 $37,902,000.00 $42,031,000.00 $41,692,000.00 $43,270,000.00 $44,243,000.00 $41,551,000.00 $13,497,000.00 $14,334,000.00 $12,028,000.00 -- -- $9,231,000.00 -- -- -- --
Long Term Debt -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital $839,759,000.00 $512,401,000.00 $507,082,000.00 $445,924,000.00 $439,890,000.00 $432,703,000.00 $428,153,000.00 $423,388,000.00 $413,967,000.00 $410,680,000.00 $407,966,000.00 -- -- $100,000.00 -- -- -- --
Accumulated Other Comprehensive Loss $-524,000.00 $665,000.00 $-1,175,000.00 $-1,060,000.00 $-739,000.00 $-1,535,000.00 $-2,277,000.00 $-1,907,000.00 $-270,000.00 $24,000.00 $17,000.00 -- -- -- -- -- -- --
Accumulated Deficit $-183,523,000.00 $-168,763,000.00 $-157,000,000.00 $-145,437,000.00 $-127,929,000.00 $-110,470,000.00 $-94,405,000.00 $-77,700,000.00 $-47,411,000.00 $-34,000,000.00 $-23,200,000.00 -- -- $-14,739,000.00 -- -- -- --
Total Stockholders' Equity $655,763,000.00 $344,349,000.00 $348,948,000.00 $299,469,000.00 $311,264,000.00 $320,740,000.00 $331,513,000.00 $343,814,000.00 $366,327,000.00 $376,750,000.00 $384,795,000.00 $-16,771,000.00 -- $-14,638,000.00 $-13,037,000.00 $-11,809,000.00 $-9,351,000.00 $-7,944,000.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $688,984,000.00 $380,407,000.00 $386,850,000.00 $341,500,000.00 $352,956,000.00 $364,010,000.00 $375,756,000.00 $385,365,000.00 $379,824,000.00 $391,084,000.00 $396,823,000.00 -- -- $16,217,000.00 -- -- -- --

Statement of Operations

Date 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 6/30/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 2/28/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019
Total Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $14,070,000.00 $54,922,000.00 $11,892,000.00 $14,924,000.00 $15,865,000.00 $53,441,000.00 $13,737,000.00 $14,086,000.00 $26,237,000.00 $8,406,000.00 $6,662,000.00 -- -- -- $834,000.00 $1,222,000.00 -- --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Loss from Operations $-20,161,000.00 $-72,979,000.00 $-15,813,000.00 $-20,748,000.00 $-20,281,000.00 $-67,091,000.00 $-18,022,000.00 $-17,261,000.00 $-32,929,000.00 $-19,439,000.00 $-8,536,000.00 -- -- -- $-3,188,000.00 $-1,932,000.00 -- --
Loss Before Income Taxes -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Basic $-0.30 $-1.32 $-1.08 $-0.42 $-0.42 $-1.52 $-1.13 $-0.73 -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Basic 49,049,741 44,016,283 43,117,403 41,836,238 41,763,971 41,469,631 41,431,023 41,448,743 445,326 457,556 447,465 -- -- -- 202,655 282,172 -- --
Earnings Per Share Diluted $-0.30 $-1.32 $-1.08 $-0.84 $-0.42 $-1.52 $-0.40 $-0.41 -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Diluted 49,049,741 44,016,283 45,708,649 41,836,238 41,763,971 41,469,631 41,526,524 41,448,743 -- -- -- -- -- -- -- -- -- --
Common Stock Shares Authorized 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 -- -- 9,000,000 -- -- -- --
Common Stock Shares Outstanding 51,840,571 46,252,440 46,151,427 41,867,536 41,802,807 41,616,260 41,550,704 41,501,269 41,243,137 41,171,963 41,094,559 -- -- 1,046,599 -- -- -- --
Common Stock Value $51,000.00 $46,000.00 $46,000.00 $42,000.00 $42,000.00 $42,000.00 $42,000.00 $42,000.00 $41,000.00 $41,000.00 $41,000.00 -- -- $1,000.00 -- -- -- --
Common Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- -- $0.00 -- -- -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 -- -- -- -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- $9.50 $0.00 -- -- -- --
Share Price -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Copyright 2024 PursePoor.com